Back
ESC Professional Premium Access

Impact of COVID-19 pandemics upon nationwide pulmonary hypertension cohort: 18-months analysis of BNP-PL national database.

Session: Covid-19 impact and management in patients with congenital heart disease and in patients with pulmonary hypertension
Topic: Pulmonary Hypertension
Speaker: Doctor A. Mamzer (Lodz, PL)
Event: ESC Congress 2022

Congress Presentation

Add to my library

Like

About the speaker

Doctor Aleksandra Mamzer

Medical University of Lodz / Bieganski Hospital, Lodz (Poland)
0 follower

5 more presentations in this session

Impact of coronavirus disease 2019 on adult patients with congenital heart disease

Speaker: Doctor I. Cardoso (Lisbon, PT)

Access
Abstract
Slides
Like
Thumbnail

Adults with congenital heart disease and COVID-19

Speaker: Miss N. Langes (Munich, DE)

Access
Abstract
Slides
Like
Thumbnail

COVID-19 infection and its impact on case-fatality in patients with pulmonary embolism

Speaker: Doctor L. Hobohm (Mainz, DE)

Access
Abstract
Slides
Like
Thumbnail

Optimal thromboprophylaxis and anticoagulant strategies in patients with COVID-19 pneumonia. The PROTHROMCOVID Trial.

Speaker: Doctor N. Munoz-Rivas (Madrid, ES)

Access
Abstract
Slides
Like
Thumbnail

COVID-19 vaccination in adults with congenital heart disease: results of 1-year prospective study

Speaker: Doctor A. Roma (Naples, IT)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Covid-19 impact and management in patients with congenital heart disease and in patients with pulmonary hypertension

Speakers: Doctor A. Mamzer, Doctor I. Cardoso, Miss N. Langes, Doctor L. Hobohm, Doctor N. Munoz-Rivas...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources